Somewhat Favorable News Coverage Somewhat Unlikely to Affect Walgreens Boots Alliance (WBA) Stock Price

News headlines about Walgreens Boots Alliance (NASDAQ:WBA) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the pharmacy operator an impact score of 47.2703134094045 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the media headlines that may have effected Accern’s analysis:

Shares of Walgreens Boots Alliance traded down $1.65, hitting $64.34, on Friday, reports. 3,388,176 shares of the company’s stock traded hands, compared to its average volume of 4,937,953. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.45 and a current ratio of 0.90. Walgreens Boots Alliance has a one year low of $61.56 and a one year high of $83.89. The firm has a market cap of $63.80 billion, a P/E ratio of 12.62, a P/E/G ratio of 1.04 and a beta of 1.15.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The company had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. During the same quarter last year, the firm earned $1.36 EPS. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. analysts forecast that Walgreens Boots Alliance will post 5.92 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.

WBA has been the topic of a number of research analyst reports. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Tuesday, May 1st. Jefferies Group set a $85.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Tuesday, April 3rd. ValuEngine lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Barclays initiated coverage on shares of Walgreens Boots Alliance in a report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target on the stock. Finally, Bank of America initiated coverage on shares of Walgreens Boots Alliance in a report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target on the stock. Two analysts have rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $83.20.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total transaction of $179,372.16. Following the transaction, the director now owns 13,679 shares of the company’s stock, valued at approximately $896,795.24. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 14.80% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Insider Buying and Selling by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with's FREE daily email newsletter.

Leave a Reply